nodes	percent_of_prediction	percent_of_DWPC	metapath
Atovaquone—CYP2C9—Nilutamide—prostate cancer	0.211	0.294	CbGbCtD
Atovaquone—CYP2C9—Bicalutamide—prostate cancer	0.211	0.294	CbGbCtD
Atovaquone—CYP2C9—Estrone—prostate cancer	0.126	0.176	CbGbCtD
Atovaquone—CYP2C9—Capecitabine—prostate cancer	0.0958	0.134	CbGbCtD
Atovaquone—CYP2C9—Estradiol—prostate cancer	0.0726	0.101	CbGbCtD
Atovaquone—DHODH—prostate gland—prostate cancer	0.0144	0.44	CbGeAlD
Atovaquone—CYP2C9—urine—prostate cancer	0.0074	0.226	CbGeAlD
Atovaquone—DHODH—testis—prostate cancer	0.00634	0.194	CbGeAlD
Atovaquone—DHODH—lymph node—prostate cancer	0.00459	0.14	CbGeAlD
Atovaquone—Azelastine—CYP3A5—prostate cancer	0.00113	0.212	CrCbGaD
Atovaquone—Azelastine—CYP2A6—prostate cancer	0.0011	0.205	CrCbGaD
Atovaquone—Azelastine—CYP2E1—prostate cancer	0.000778	0.146	CrCbGaD
Atovaquone—Azelastine—CYP2C19—prostate cancer	0.000771	0.144	CrCbGaD
Atovaquone—Azelastine—CYP1A1—prostate cancer	0.000768	0.144	CrCbGaD
Atovaquone—Azelastine—CYP3A4—prostate cancer	0.00049	0.0919	CrCbGaD
Atovaquone—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.000309	0.00126	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP7B1—prostate cancer	0.000306	0.00125	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—SLC5A5—prostate cancer	0.000305	0.00124	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—SULT1E1—prostate cancer	0.000302	0.00123	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	0.000302	0.00123	CbGpPWpGaD
Atovaquone—Prazepam—CYP3A4—prostate cancer	0.0003	0.0563	CrCbGaD
Atovaquone—CYP2C9—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	0.000299	0.00122	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—SULT1E1—prostate cancer	0.000298	0.00121	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CYP2E1—prostate cancer	0.000298	0.00121	CbGpPWpGaD
Atovaquone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	0.000295	0.0012	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—NQO1—prostate cancer	0.000295	0.0012	CbGpPWpGaD
Atovaquone—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	0.000291	0.00119	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—TH—prostate cancer	0.00029	0.00118	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	0.000288	0.00117	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CYP3A4—prostate cancer	0.000287	0.00117	CbGpPWpGaD
Atovaquone—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.000284	0.00116	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CYP1B1—prostate cancer	0.000282	0.00115	CbGpPWpGaD
Atovaquone—CYP2C9—Arachidonic acid metabolism—CYP1A1—prostate cancer	0.000275	0.00112	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GGT1—prostate cancer	0.000274	0.00112	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—NCOA1—prostate cancer	0.000269	0.0011	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.000268	0.00109	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP3A5—prostate cancer	0.000266	0.00108	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CYP19A1—prostate cancer	0.000266	0.00108	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP3A5—prostate cancer	0.000262	0.00107	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000258	0.00105	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTA3—prostate cancer	0.000257	0.00105	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—RXRA—prostate cancer	0.000256	0.00104	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.000254	0.00104	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTA3—prostate cancer	0.000253	0.00103	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—COMT—prostate cancer	0.000247	0.00101	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GSTP1—prostate cancer	0.000246	0.001	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	0.000242	0.000988	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—ITPR1—prostate cancer	0.000242	0.000986	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	0.000239	0.000974	CbGpPWpGaD
Atovaquone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	0.000238	0.000968	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—TBXAS1—prostate cancer	0.000235	0.000958	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTA4—prostate cancer	0.000235	0.000958	CbGpPWpGaD
Atovaquone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.000234	0.000956	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTA4—prostate cancer	0.000232	0.000945	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	0.000231	0.00094	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTA2—prostate cancer	0.000229	0.000934	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—TYMS—prostate cancer	0.000228	0.000931	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—SULT1A1—prostate cancer	0.000226	0.000922	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—GSTM1—prostate cancer	0.000226	0.000921	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—SULT1A1—prostate cancer	0.000223	0.00091	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—LPL—prostate cancer	0.000222	0.000904	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTA1—prostate cancer	0.000221	0.000901	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—NAT2—prostate cancer	0.000218	0.000891	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTO1—prostate cancer	0.000218	0.000891	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTO1—prostate cancer	0.000215	0.000878	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—NAT2—prostate cancer	0.000215	0.000878	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CYP1A1—prostate cancer	0.000214	0.000873	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—ERCC2—prostate cancer	0.000212	0.000866	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP2C18—prostate cancer	0.000209	0.000854	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP2C18—prostate cancer	0.000207	0.000842	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—MTHFR—prostate cancer	0.0002	0.000814	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PPARA—prostate cancer	0.000196	0.000798	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—SULT2A1—prostate cancer	0.000195	0.000794	CbGpPWpGaD
Atovaquone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000193	0.000785	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—SULT2A1—prostate cancer	0.000192	0.000783	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.000185	0.000753	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.000185	0.000753	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CAV1—prostate cancer	0.000184	0.000751	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GPX3—prostate cancer	0.000183	0.000747	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—HPGDS—prostate cancer	0.000175	0.000712	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP2C19—prostate cancer	0.000174	0.000708	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP2C19—prostate cancer	0.000171	0.000698	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTT1—prostate cancer	0.000169	0.000691	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PIK3CG—prostate cancer	0.000168	0.000684	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP2A6—prostate cancer	0.000167	0.000683	CbGpPWpGaD
Atovaquone—CYP2C9—Arachidonic acid metabolism—PTGS2—prostate cancer	0.000163	0.000666	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.000162	0.000658	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—AKR1C3—prostate cancer	0.000161	0.000655	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP17A1—prostate cancer	0.00016	0.000654	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—INS—prostate cancer	0.000159	0.000647	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP17A1—prostate cancer	0.000158	0.000645	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—CREBBP—prostate cancer	0.000155	0.000634	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.000153	0.000624	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.000153	0.000624	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.000153	0.000624	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—NCOA2—prostate cancer	0.000153	0.000623	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PIK3CD—prostate cancer	0.000147	0.000601	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.000146	0.000595	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP2E1—prostate cancer	0.000142	0.00058	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP2E1—prostate cancer	0.00014	0.000572	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—NOS3—prostate cancer	0.000139	0.000567	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP3A4—prostate cancer	0.000137	0.00056	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP3A4—prostate cancer	0.000135	0.000552	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP1B1—prostate cancer	0.000135	0.00055	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP1B1—prostate cancer	0.000133	0.000543	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GGT1—prostate cancer	0.000131	0.000533	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.00013	0.000531	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—NCOA1—prostate cancer	0.000129	0.000525	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PIK3CB—prostate cancer	0.000128	0.000524	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PTGS2—prostate cancer	0.000127	0.000519	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP19A1—prostate cancer	0.000127	0.000517	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP19A1—prostate cancer	0.000125	0.00051	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—RXRA—prostate cancer	0.000122	0.000499	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.000122	0.000499	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.000119	0.000485	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—COMT—prostate cancer	0.000118	0.000481	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTP1—prostate cancer	0.000117	0.000479	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—COMT—prostate cancer	0.000116	0.000474	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.000116	0.000473	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTP1—prostate cancer	0.000116	0.000472	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PTEN—prostate cancer	0.000111	0.000453	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.000111	0.000451	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.000111	0.000451	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—GSTM1—prostate cancer	0.000108	0.00044	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—GSTM1—prostate cancer	0.000106	0.000434	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—EP300—prostate cancer	0.000106	0.000432	CbGpPWpGaD
Atovaquone—CYP2C9—Biological oxidations—CYP1A1—prostate cancer	0.000102	0.000417	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HAO1—prostate cancer	0.000101	0.000412	CbGpPWpGaD
Atovaquone—CYP2C9—Metapathway biotransformation—CYP1A1—prostate cancer	0.000101	0.000411	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	9.41e-05	0.000384	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	9.02e-05	0.000368	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	8.69e-05	0.000354	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	8.39e-05	0.000342	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GRHL1—prostate cancer	8.23e-05	0.000335	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TST—prostate cancer	8.23e-05	0.000335	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PSAT1—prostate cancer	8.23e-05	0.000335	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CSAD—prostate cancer	8.23e-05	0.000335	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ADI1—prostate cancer	8.23e-05	0.000335	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CBR1—prostate cancer	8.23e-05	0.000335	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	8.04e-05	0.000328	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	7.89e-05	0.000322	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—PIK3CA—prostate cancer	7.83e-05	0.000319	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—UGT2B17—prostate cancer	7.65e-05	0.000312	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GRHPR—prostate cancer	7.65e-05	0.000312	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—UGT2B15—prostate cancer	7.65e-05	0.000312	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CKMT2—prostate cancer	7.65e-05	0.000312	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	7.48e-05	0.000305	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	7.36e-05	0.0003	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—MBTPS1—prostate cancer	7.19e-05	0.000293	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SULT2B1—prostate cancer	7.19e-05	0.000293	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NAGLU—prostate cancer	7.19e-05	0.000293	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—AOX1—prostate cancer	7.19e-05	0.000293	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PGAM2—prostate cancer	7.19e-05	0.000293	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—RFK—prostate cancer	7.19e-05	0.000293	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTM3—prostate cancer	7.19e-05	0.000293	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	7.03e-05	0.000287	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—AMACR—prostate cancer	6.82e-05	0.000278	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP3A43—prostate cancer	6.82e-05	0.000278	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SRD5A2—prostate cancer	6.82e-05	0.000278	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NAT1—prostate cancer	6.82e-05	0.000278	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—DEGS1—prostate cancer	6.82e-05	0.000278	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	6.71e-05	0.000273	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	6.66e-05	0.000272	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HSD17B1—prostate cancer	6.51e-05	0.000265	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	6.51e-05	0.000265	CbGpPWpGaD
Atovaquone—DHODH—Metabolism—AKT1—prostate cancer	6.4e-05	0.000261	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	6.26e-05	0.000255	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	6.22e-05	0.000254	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	6.16e-05	0.000251	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	5.87e-05	0.000239	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HPGD—prostate cancer	5.8e-05	0.000236	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—B4GALT4—prostate cancer	5.8e-05	0.000236	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TNFRSF21—prostate cancer	5.45e-05	0.000222	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP7B1—prostate cancer	5.3e-05	0.000216	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—MTAP—prostate cancer	5.3e-05	0.000216	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.18e-05	0.000211	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SULT1E1—prostate cancer	5.17e-05	0.000211	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SRD5A1—prostate cancer	5.17e-05	0.000211	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.02e-05	0.000205	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	4.94e-05	0.000202	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HSD17B3—prostate cancer	4.93e-05	0.000201	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ACSL4—prostate cancer	4.93e-05	0.000201	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	4.87e-05	0.000199	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PHGDH—prostate cancer	4.73e-05	0.000193	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—UMPS—prostate cancer	4.73e-05	0.000193	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ARG2—prostate cancer	4.73e-05	0.000193	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.7e-05	0.000192	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—LDHB—prostate cancer	4.64e-05	0.000189	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP3A5—prostate cancer	4.55e-05	0.000185	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TCN2—prostate cancer	4.39e-05	0.000179	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—UCP3—prostate cancer	4.39e-05	0.000179	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PDHA1—prostate cancer	4.39e-05	0.000179	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTA3—prostate cancer	4.39e-05	0.000179	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HSD3B1—prostate cancer	4.19e-05	0.000171	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SLC22A3—prostate cancer	4.19e-05	0.000171	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.07e-05	0.000166	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTA4—prostate cancer	4.02e-05	0.000164	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TBXAS1—prostate cancer	4.02e-05	0.000164	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.93e-05	0.00016	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTA2—prostate cancer	3.92e-05	0.00016	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SULT1A1—prostate cancer	3.87e-05	0.000158	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ABCG5—prostate cancer	3.87e-05	0.000158	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTA1—prostate cancer	3.78e-05	0.000154	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTO1—prostate cancer	3.74e-05	0.000152	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NAT2—prostate cancer	3.74e-05	0.000152	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HSD3B2—prostate cancer	3.74e-05	0.000152	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.59e-05	0.000146	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PLCB2—prostate cancer	3.58e-05	0.000146	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—LRP2—prostate cancer	3.58e-05	0.000146	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP2C18—prostate cancer	3.58e-05	0.000146	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—P4HB—prostate cancer	3.51e-05	0.000143	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SLC22A1—prostate cancer	3.42e-05	0.000139	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.38e-05	0.000138	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SULT2A1—prostate cancer	3.33e-05	0.000136	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—MED12—prostate cancer	3.28e-05	0.000134	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GNG5—prostate cancer	3.25e-05	0.000133	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NCOA3—prostate cancer	3.13e-05	0.000128	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.08e-05	0.000125	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—HPGDS—prostate cancer	2.99e-05	0.000122	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP2C19—prostate cancer	2.97e-05	0.000121	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ACHE—prostate cancer	2.9e-05	0.000118	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTT1—prostate cancer	2.9e-05	0.000118	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP2A6—prostate cancer	2.86e-05	0.000117	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.85e-05	0.000116	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—AKR1C3—prostate cancer	2.79e-05	0.000114	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PRKACB—prostate cancer	2.77e-05	0.000113	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP17A1—prostate cancer	2.74e-05	0.000112	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.7e-05	0.00011	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NCOA2—prostate cancer	2.61e-05	0.000107	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.49e-05	0.000102	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.43e-05	9.93e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NQO1—prostate cancer	2.41e-05	9.81e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TH—prostate cancer	2.37e-05	9.67e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.36e-05	9.61e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.35e-05	9.57e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.34e-05	9.52e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.31e-05	9.41e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GGT1—prostate cancer	2.24e-05	9.11e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NCOA1—prostate cancer	2.2e-05	8.98e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.17e-05	8.85e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—RXRA—prostate cancer	2.09e-05	8.54e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.04e-05	8.3e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—COMT—prostate cancer	2.02e-05	8.22e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTP1—prostate cancer	2.01e-05	8.19e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ITPR1—prostate cancer	1.98e-05	8.05e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.94e-05	7.92e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—TYMS—prostate cancer	1.87e-05	7.61e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—GSTM1—prostate cancer	1.85e-05	7.52e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—LPL—prostate cancer	1.81e-05	7.38e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.75e-05	7.13e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—ERCC2—prostate cancer	1.73e-05	7.07e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—MTHFR—prostate cancer	1.63e-05	6.65e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PPARA—prostate cancer	1.6e-05	6.52e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CAV1—prostate cancer	1.5e-05	6.13e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.44e-05	5.86e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.37e-05	5.59e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—INS—prostate cancer	1.3e-05	5.29e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—CREBBP—prostate cancer	1.27e-05	5.18e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.2e-05	4.91e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—NOS3—prostate cancer	1.14e-05	4.64e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.05e-05	4.28e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PTGS2—prostate cancer	1.04e-05	4.24e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PTEN—prostate cancer	9.07e-06	3.7e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—EP300—prostate cancer	8.65e-06	3.53e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.4e-06	2.61e-05	CbGpPWpGaD
Atovaquone—CYP2C9—Metabolism—AKT1—prostate cancer	5.23e-06	2.13e-05	CbGpPWpGaD
